ID   OLA1_HUMAN              Reviewed;         396 AA.
AC   Q9NTK5; D7EHM2; Q5BJD7; Q8NCI8; Q96CU1; Q96SV2; Q9P1D3; Q9UNY9;
AC   Q9Y6G4;
DT   25-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2002, sequence version 2.
DT   04-FEB-2015, entry version 138.
DE   RecName: Full=Obg-like ATPase 1 {ECO:0000255|HAMAP-Rule:MF_03167};
DE   AltName: Full=DNA damage-regulated overexpressed in cancer 45;
DE            Short=DOC45;
DE   AltName: Full=GTP-binding protein 9;
GN   Name=OLA1 {ECO:0000255|HAMAP-Rule:MF_03167}; Synonyms=GTPBP9;
GN   ORFNames=PRO2455, PTD004;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   INDUCTION.
RX   PubMed=20053727; DOI=10.1158/1541-7786.MCR-09-0278;
RA   Sun H., Luo X., Montalbano J., Jin W., Shi J., Sheikh M.S., Huang Y.;
RT   "DOC45, a novel DNA damage-regulated nucleocytoplasmic ATPase that is
RT   overexpressed in multiple human malignancies.";
RL   Mol. Cancer Res. 8:57-66(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Yue P., Yu L., Zhao S.Y.;
RT   "Cloning of a new human cDNA homologous to Caenorhabditis elegans
RT   putative GTP-binding protein.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pituitary tumor;
RA   Zhang Q., Huang Q., Song H., Peng J., Fu G., Mao M., Dai M., Mao Y.,
RA   Zhou J., Chen Z., Chen J., Luo M., Hu R.;
RT   "Human homologous yeast-44.2 protein, complete cds.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Wei H., Zhou G., Ouyang S., Luo L., Bi J.,
RA   Liu M., He F.;
RT   "Functional prediction of the coding sequences of 121 new genes
RT   deduced by analysis of cDNA clones from human fetal liver.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, Ovary, Testis, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-294, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) IN COMPLEX WITH ATP ANALOG,
RP   SUBUNIT, AND MUTAGENESIS OF PHE-127; ASN-230 AND 231-LEU--GLU-233.
RX   PubMed=17430889; DOI=10.1074/jbc.M700541200;
RA   Koller-Eichhorn R., Marquardt T., Gail R., Wittinghofer A.,
RA   Kostrewa D., Kutay U., Kambach C.;
RT   "Human OLA1 defines an ATPase subfamily in the Obg family of GTP-
RT   binding proteins.";
RL   J. Biol. Chem. 282:19928-19937(2007).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-168.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Hydrolyzes ATP, and can also hydrolyze GTP with lower
CC       efficiency. Has lower affinity for GTP.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_03167,
CC       ECO:0000269|PubMed:17430889}.
CC   -!- INTERACTION:
CC       P04591:gag (xeno); NbExp=4; IntAct=EBI-766468, EBI-6179719;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03167,
CC       ECO:0000269|PubMed:20053727}. Nucleus {ECO:0000255|HAMAP-
CC       Rule:MF_03167, ECO:0000269|PubMed:20053727}. Nucleus, nucleolus
CC       {ECO:0000255|HAMAP-Rule:MF_03167, ECO:0000269|PubMed:20053727}.
CC       Note=Predominantly cytoplasmic, shuttles between the nucleus and
CC       the cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NTK5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NTK5-2; Sequence=VSP_002049;
CC       Name=3;
CC         IsoId=Q9NTK5-3; Sequence=VSP_002050, VSP_002051;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested but its
CC       expression is more abundant in testis, liver, lung, and brain.
CC       Overexpressed in several malignancies, including cancers of the
CC       colon, rectum, ovary, lung, stomach, and uterus.
CC   -!- INDUCTION: Strongly down-regulated by DNA damage-inducing agents.
CC       {ECO:0000269|PubMed:20053727}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class OBG-HflX-like GTPase
CC       superfamily. OBG GTPase family. YchF/OLA1 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03167}.
CC   -!- SIMILARITY: Contains 1 OBG-type G (guanine nucleotide-binding)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ250006; ABB72766.1; -; mRNA.
DR   EMBL; AF134478; AAP97255.1; -; mRNA.
DR   EMBL; AL136546; CAB66481.1; -; mRNA.
DR   EMBL; AF078859; AAD44491.1; -; mRNA.
DR   EMBL; AF078868; AAD44500.1; -; mRNA.
DR   EMBL; AF116703; AAF71123.1; -; mRNA.
DR   EMBL; AK027523; BAB55174.1; -; mRNA.
DR   EMBL; AK074710; BAC11153.1; -; mRNA.
DR   EMBL; CH471058; EAX11151.1; -; Genomic_DNA.
DR   EMBL; BC012842; AAH12842.1; -; mRNA.
DR   EMBL; BC013925; AAH13925.1; -; mRNA.
DR   EMBL; BC029376; AAH29376.1; -; mRNA.
DR   EMBL; BC091522; AAH91522.1; -; mRNA.
DR   CCDS; CCDS2255.1; -. [Q9NTK5-1]
DR   CCDS; CCDS42779.1; -. [Q9NTK5-2]
DR   PIR; T46901; T46901.
DR   RefSeq; NP_001011708.1; NM_001011708.1. [Q9NTK5-2]
DR   RefSeq; NP_037473.3; NM_013341.3. [Q9NTK5-1]
DR   UniGene; Hs.157351; -.
DR   PDB; 2OHF; X-ray; 2.70 A; A=1-396.
DR   PDBsum; 2OHF; -.
DR   ProteinModelPortal; Q9NTK5; -.
DR   SMR; Q9NTK5; 16-388.
DR   BioGrid; 118917; 34.
DR   IntAct; Q9NTK5; 8.
DR   MINT; MINT-1407274; -.
DR   STRING; 9606.ENSP00000284719; -.
DR   PhosphoSite; Q9NTK5; -.
DR   DMDM; 25453240; -.
DR   OGP; Q9NTK5; -.
DR   UCD-2DPAGE; Q9NTK5; -.
DR   MaxQB; Q9NTK5; -.
DR   PaxDb; Q9NTK5; -.
DR   PRIDE; Q9NTK5; -.
DR   DNASU; 29789; -.
DR   Ensembl; ENST00000284719; ENSP00000284719; ENSG00000138430. [Q9NTK5-1]
DR   Ensembl; ENST00000344357; ENSP00000340167; ENSG00000138430. [Q9NTK5-2]
DR   Ensembl; ENST00000428402; ENSP00000410385; ENSG00000138430. [Q9NTK5-3]
DR   GeneID; 29789; -.
DR   KEGG; hsa:29789; -.
DR   UCSC; uc002uih.3; human. [Q9NTK5-1]
DR   UCSC; uc010fqr.3; human. [Q9NTK5-3]
DR   CTD; 29789; -.
DR   GeneCards; GC02M174937; -.
DR   HGNC; HGNC:28833; OLA1.
DR   HPA; HPA035790; -.
DR   MIM; 611175; gene.
DR   neXtProt; NX_Q9NTK5; -.
DR   PharmGKB; PA162398388; -.
DR   eggNOG; COG0012; -.
DR   GeneTree; ENSGT00390000000673; -.
DR   HOVERGEN; HBG031861; -.
DR   InParanoid; Q9NTK5; -.
DR   KO; K06942; -.
DR   OrthoDB; EOG7X3QQF; -.
DR   PhylomeDB; Q9NTK5; -.
DR   TreeFam; TF300774; -.
DR   ChiTaRS; OLA1; human.
DR   EvolutionaryTrace; Q9NTK5; -.
DR   GeneWiki; OLA1; -.
DR   GenomeRNAi; 29789; -.
DR   NextBio; 52323; -.
DR   PRO; PR:Q9NTK5; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; Q9NTK5; -.
DR   CleanEx; HS_OLA1; -.
DR   ExpressionAtlas; Q9NTK5; baseline and differential.
DR   Genevestigator; Q9NTK5; -.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0070062; C:extracellular vesicular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:HGNC.
DR   GO; GO:0016887; F:ATPase activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0005525; F:GTP binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043023; F:ribosomal large subunit binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0043022; F:ribosome binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0006200; P:ATP catabolic process; IDA:HGNC.
DR   Gene3D; 1.10.150.300; -; 1.
DR   Gene3D; 3.10.20.30; -; 1.
DR   Gene3D; 3.40.50.300; -; 2.
DR   HAMAP; MF_00944; YchF_OLA1_ATPase; 1.
DR   InterPro; IPR004396; ATPase_YchF/OLA1.
DR   InterPro; IPR012675; Beta-grasp_dom.
DR   InterPro; IPR013029; DUF933.
DR   InterPro; IPR006073; GTP_binding_domain.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR012676; TGS-like.
DR   InterPro; IPR023192; TGS-like_dom.
DR   Pfam; PF01926; MMR_HSR1; 1.
DR   Pfam; PF06071; YchF-GTPase_C; 1.
DR   PIRSF; PIRSF006641; CHP00092; 1.
DR   PRINTS; PR00326; GTP1OBG.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF81271; SSF81271; 1.
DR   TIGRFAMs; TIGR00092; TIGR00092; 1.
DR   PROSITE; PS51710; G_OBG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Hydrolase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Polymorphism; Reference proteome.
FT   CHAIN         1    396       Obg-like ATPase 1.
FT                                /FTId=PRO_0000122456.
FT   DOMAIN       23    283       OBG-type G.
FT   NP_BIND      32     37       ATP.
FT   MOTIF       267    274       Nuclear export signal.
FT                                {ECO:0000255|HAMAP-Rule:MF_03167}.
FT   METAL        36     36       Magnesium. {ECO:0000250}.
FT   METAL        56     56       Magnesium. {ECO:0000250}.
FT   BINDING     231    231       ATP; via carbonyl oxygen.
FT   MOD_RES     294    294       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19608861}.
FT   VAR_SEQ       1    158       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_002049.
FT   VAR_SEQ     245    278       IKIKEWVDKYDPGALVIPFSGALELKLQELSAEE -> LES
FT                                TDNKAEIILLKMEILSSSNLTHLNNRRRNKI (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_002050.
FT   VAR_SEQ     279    396       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_002051.
FT   VARIANT     168    168       E -> Q (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036613.
FT   MUTAGEN     127    127       F->A: Loss of ATP-binding.
FT                                {ECO:0000269|PubMed:17430889}.
FT   MUTAGEN     230    230       N->A: Loss of ATP-binding.
FT                                {ECO:0000269|PubMed:17430889}.
FT   MUTAGEN     231    233       LSE->KSD: Retention of ATP-binding
FT                                specificity.
FT                                {ECO:0000269|PubMed:17430889}.
FT   CONFLICT     33     33       V -> A (in Ref. 6; BAB55174).
FT                                {ECO:0000305}.
FT   CONFLICT     97     97       V -> A (in Ref. 4; AAD44500).
FT                                {ECO:0000305}.
FT   CONFLICT    254    254       Y -> C (in Ref. 3; CAB66481).
FT                                {ECO:0000305}.
FT   CONFLICT    391    391       Q -> R (in Ref. 5; AAF71123).
FT                                {ECO:0000305}.
FT   STRAND       19     21       {ECO:0000244|PDB:2OHF}.
FT   STRAND       25     28       {ECO:0000244|PDB:2OHF}.
FT   STRAND       31     34       {ECO:0000244|PDB:2OHF}.
FT   HELIX        35     43       {ECO:0000244|PDB:2OHF}.
FT   STRAND       60     65       {ECO:0000244|PDB:2OHF}.
FT   HELIX        69     78       {ECO:0000244|PDB:2OHF}.
FT   STRAND       81     84       {ECO:0000244|PDB:2OHF}.
FT   STRAND       87     92       {ECO:0000244|PDB:2OHF}.
FT   HELIX       109    115       {ECO:0000244|PDB:2OHF}.
FT   STRAND      117    125       {ECO:0000244|PDB:2OHF}.
FT   HELIX       142    165       {ECO:0000244|PDB:2OHF}.
FT   HELIX       182    192       {ECO:0000244|PDB:2OHF}.
FT   HELIX       200    202       {ECO:0000244|PDB:2OHF}.
FT   HELIX       208    217       {ECO:0000244|PDB:2OHF}.
FT   HELIX       220    222       {ECO:0000244|PDB:2OHF}.
FT   STRAND      225    230       {ECO:0000244|PDB:2OHF}.
FT   HELIX       233    238       {ECO:0000244|PDB:2OHF}.
FT   HELIX       242    254       {ECO:0000244|PDB:2OHF}.
FT   STRAND      259    263       {ECO:0000244|PDB:2OHF}.
FT   HELIX       265    273       {ECO:0000244|PDB:2OHF}.
FT   HELIX       276    285       {ECO:0000244|PDB:2OHF}.
FT   HELIX       292    302       {ECO:0000244|PDB:2OHF}.
FT   STRAND      305    322       {ECO:0000244|PDB:2OHF}.
FT   HELIX       327    332       {ECO:0000244|PDB:2OHF}.
FT   HELIX       337    341       {ECO:0000244|PDB:2OHF}.
FT   STRAND      342    348       {ECO:0000244|PDB:2OHF}.
FT   HELIX       350    356       {ECO:0000244|PDB:2OHF}.
FT   HELIX       359    364       {ECO:0000244|PDB:2OHF}.
FT   STRAND      369    371       {ECO:0000244|PDB:2OHF}.
FT   STRAND      382    387       {ECO:0000244|PDB:2OHF}.
SQ   SEQUENCE   396 AA;  44744 MW;  4C7629BFC27CBEB2 CRC64;
     MPPKKGGDGI KPPPIIGRFG TSLKIGIVGL PNVGKSTFFN VLTNSQASAE NFPFCTIDPN
     ESRVPVPDER FDFLCQYHKP ASKIPAFLNV VDIAGLVKGA HNGQGLGNAF LSHISACDGI
     FHLTRAFEDD DITHVEGSVD PIRDIEIIHE ELQLKDEEMI GPIIDKLEKV AVRGGDKKLK
     PEYDIMCKVK SWVIDQKKPV RFYHDWNDKE IEVLNKHLFL TSKPMVYLVN LSEKDYIRKK
     NKWLIKIKEW VDKYDPGALV IPFSGALELK LQELSAEERQ KYLEANMTQS ALPKIIKAGF
     AALQLEYFFT AGPDEVRAWT IRKGTKAPQA AGKIHTDFEK GFIMAEVMKY EDFKEEGSEN
     AVKAAGKYRQ QGRNYIVEDG DIIFFKFNTP QQPKKK
//
